방사선의학 웹진

바로가기  >

Abstract

Heat shock protein 27 (HSP27, HSPB1) is an anti-apoptotic protein characterized for its tumorigenic and metastatic properties, and now referenced as a major therapeutic target in many types of cancer. The biochemical properties of HSP27 rely on a structural oligomeric and dynamic organization that is important for its chaperone activity. Down-regulation by small interfering RNA or inhibition with a dominant-negative mutant efficiently counteracts the anti-apoptotic and protective properties of HSP27. However, unlike other HSPs such as HSP90 and HSP70, small molecule approaches for neutralization of HSP27 are not well established because of the absence of an ATP binding domain. Previously, we found that a small molecule, zerumbone (ZER), induced altered dimerization of HSP27 by cross linking the cysteine residues required to build a large oligomer, led to sensitization in combination with radiation. In this study, we identified another small molecule, a xanthone compound, more capable of altering dimeric HSP27 than ZER and yielding sensitization in human lung cancer cells when combined with HSP90 inhibitors or standard anticancer modalities such as irradiation and cytotoxic anticancer drugs. Therefore, altered dimerization of HSP27 represents a good strategy for anticancer therapy in HSP27-overexpressing cancer cells. 

Author information

Kim JH1, Jung YJ1, Choi B1, Lee NL1, Lee HJ2, Kwak SY3, Kwon Y1, Na Y3, Lee YS1.​

1Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 120-720, Korea.

2Division of Radiation Effects, Korea Institute of Radiological and Medical Sciences, Seoul, 139-706, Korea.

3College of Pharmacy, CHA University, Pocheon, 487-010, Korea.